Erythrocyte‐Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects

Abstract Despite being a new promising tool for cancer therapy, intravenous delivery of oncolytic viruses (OVs) is greatly limited by poor tumor targeting, rapid clearance in the blood, severe organ toxicity, and cytokine release syndrome. Herein, a simple and efficient strategy of erythrocyte‐lever...

Description complète

Détails bibliographiques

Auteurs principaux:	Mingyang Liu, Ruizhe Zhang, Hanwei Huang, Pengfei Liu, Xu Zhao, Hu Wu, Ying He, Ruizhe Xu, Xifeng Qin, Zhenguo Cheng, Hongyu Liu, Onder Ergonul, Füsun Can, Defang Ouyang, Zhenning Wang, Zhiqing Pang, Funan Liu
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2024-02-01
Collection:	Advanced Science
Sujets:	biocompatibility erythrocytes hitchhiking oncolytic virus targeted delivery
Accès en ligne:	https://doi.org/10.1002/advs.202303907
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!